B. Kemp Dolliver
Class of '83, Darden Class of '87
Kemp Dolliver is Head of Healthcare Research - Asia and Managing Director for Religare Capital Markets (Singapore) Pte. Ltd. Previously, he was Managing Director of Avondale Partners LLC, where he was a Senior Analyst covering health care services companies, and led the health care research team. He joined Avondale in June 2009 after 12 years at Cowen and Company LLC. Before joining Cowen, he worked for 10 years in investment management for NationsBank (now Bank of America) and Aetna, primarily covering health care. The Wall Street Journal has cited him four times in its “Best on the Street” survey for stock picking. He was on the editorial advisory board of Drug Benefit News, a trade publication covering the PBM industry. He has spoken at numerous industry conferences, and numerous publications have quoted him on health care industry developments. After graduating from the McIntire School in 1983, Mr. Dolliver worked in mergers and acquisitions for Dean Witter Reynolds for two years, and then entered the Darden School, graduating in 1987 with an M.B.A. He is a Chartered Financial Analyst.